Filter Search


Europe


Location Summary Deadline
Germany Open House Biologics Discount Agreements 2024-10 - Pertuzumab / Trastuzumab (drug Combination) 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (atc 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Tadalafil (g04be08), Only Medicinal Products With The Indication Benign Prostatic Syndrome 2026-12-31
Ireland Dps For The Provision Of Needles And Syringes For Use In National Immunisation Programmes 2026-12-31
Germany Openhouseoriginalerabattvertrage 202414 Bimatoprost / Timolol (dosage Form 2026-12-31
United Kingdom Alternative Education Provision In Nottinghamshire 2026-12-31
Germany Ceftazidime (pii, N3)_tk, Hek, Hkk 2026-12-31
Germany Valganciclovir (fta: 450 Mg, 30 St.)_tk, Hek, Hkk 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Whats app